CY1107334T1 - METHODS FOR REDUCING VASCULATION - Google Patents

METHODS FOR REDUCING VASCULATION

Info

Publication number
CY1107334T1
CY1107334T1 CY20061101433T CY061101433T CY1107334T1 CY 1107334 T1 CY1107334 T1 CY 1107334T1 CY 20061101433 T CY20061101433 T CY 20061101433T CY 061101433 T CY061101433 T CY 061101433T CY 1107334 T1 CY1107334 T1 CY 1107334T1
Authority
CY
Cyprus
Prior art keywords
methods
vasculation
reducing
inhibiting
oleuropein
Prior art date
Application number
CY20061101433T
Other languages
Greek (el)
Inventor
Hamdi K Hamdi
Jeffrey H Tavis
Raquel Castellon
Original Assignee
Hamdi, Hamdi K.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02739332A external-priority patent/EP1397105B1/en
Application filed by Hamdi, Hamdi K. filed Critical Hamdi, Hamdi K.
Publication of CY1107334T1 publication Critical patent/CY1107334T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Αποκαλύπτονται μέθοδοι για την αναστολή της αγγειογένεσης, που περιλαμβάνουν τη χορήγηση ελαιοευρωπαΐνης και/ή των προϊόντων της υδρόλυσής της σε θεραπευτικώς αποτελεσματικές ποσότητες. Οι μέθοδοι και οι συνθέσεις της παρούσας εφεύρεσης είναι ιδιαίτερα αποτελεσματικές στην αναστολή της αγγείωσης των ενδοθηλιακών κυττάρων, και μπορούν να χρησιμοποιηθούν για τη θεραπευτική αντιμετώπιση μίας ευρείας ποικιλίας καρκίνων, οφθαλμικών παθήσεων, και φλεγμονωδών συνθηκών.Methods for inhibiting angiogenesis, including administration of oleuropein and / or its hydrolysis products in therapeutically effective amounts, are disclosed. The methods and compositions of the present invention are particularly effective in inhibiting endothelial cell vasculature, and can be used to treat a wide variety of cancers, ocular diseases, and inflammatory conditions.

CY20061101433T 2001-05-23 2006-10-04 METHODS FOR REDUCING VASCULATION CY1107334T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22294701A 2001-05-23 2001-05-23
EP02739332A EP1397105B1 (en) 2001-05-23 2002-05-22 Compositions for inhibiting angiogenesis

Publications (1)

Publication Number Publication Date
CY1107334T1 true CY1107334T1 (en) 2012-12-19

Family

ID=49546188

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101433T CY1107334T1 (en) 2001-05-23 2006-10-04 METHODS FOR REDUCING VASCULATION

Country Status (1)

Country Link
CY (1) CY1107334T1 (en)

Similar Documents

Publication Publication Date Title
ATE333882T1 (en) COMPOSITIONS FOR INHIBITING ANGIOGENESIS
TR200200160T2 (en) Imidazoles and triazoles as anti-inflammatory agents
ATE324444T1 (en) TEK ANTAGONISTS
CY1105286T1 (en) O-CARBOXYARYLYPOsubstituted BINYLUREAS AS RAF KINASE INHIBITORS
CY1109693T1 (en) Substituted Imidazoles as Suspensions TAFIa
BR9914044A (en) tetrahydropyride esters
CY1115580T1 (en) COMPOSITION AND ANTI-VIVAL ACTIVITY OF SUBSTITUTED AZAIDOLOLOXIC Piperazine Derivatives
ECSP044992A (en) INHIBITORS OF THE ALQUÍN-ARIL FOSFODIESTERASA-4
TR200103575T2 (en) Sulfonamide and sulfamide substituted / doped imidazoquinolines
ECSP055844A (en) NEW TRICYCLE COMPOUNDS
ATE448232T1 (en) SUBSTITUTED HETEROCYCLES
ES2192839T3 (en) TIMOSINA BETA 4 OXIDADA.
ATE332302T1 (en) ALKYLATED IMIDAZOPYRIDINE DERIVATIVES
SV2002000235A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE VALDECOXIB
DE60115466D1 (en) ACTIVE PROCESSORS OF IMIDAZOPYRIDINE DERIVATIVES
ATE365735T1 (en) CYCLOALKYLSULFANYL-SUBSTITUTED BENZO BÖTHIOPHENE AS THERAPEUTIC AGENTS
CY1109187T1 (en) NEW MACROLIDES
SE0003476D0 (en) Compounds
EE200100125A (en) TAN-1057 derivatives
IS6130A (en) Anti-inflammatory treatment for inflammation associated with infection
ATE335739T1 (en) CAK INHIBITORS AND THEIR USES
CY1107334T1 (en) METHODS FOR REDUCING VASCULATION
DE60003074D1 (en) Fusidic DERIVATIVES
SE0001631D0 (en) New use
MXPA04006120A (en) Piperidine-2,6-diones that are heterocyclically substituted in position 3.